Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compactotomy in Huntington's chorea.

R M Bonelli1, L Kenner, A Gruber

  • 1Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria. rm.bonelli@nextra.at

Medical Hypotheses
|October 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same author

Simultaneous Probe of the Charm and Bottom Quark Yukawa Couplings Using tt[over ¯]H Events.

Physical review letters·2026
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Functional neurosurgery is advancing for movement disorders. A case study suggests deep brain stimulation of the substantia nigra pars compacta could treat Huntington

Area of Science:

  • Neuroscience
  • Neurosurgery
  • Movement Disorders

Background:

  • Functional neurosurgery is increasingly used for movement disorders like Parkinson's disease.
  • Hyperkinetic disorders, such as Huntington's disease (HD), have fewer treatment options due to target identification challenges.

Purpose of the Study:

  • To investigate a potential neurosurgical target for ameliorating hyperkinesia in Huntington's disease.
  • To propose deep brain stimulation of the substantia nigra pars compacta as a novel therapeutic strategy for chorea.

Main Methods:

  • Case study of a genetically confirmed Huntington's disease patient with reversible chorea.
  • Analysis of neuroradiological findings, specifically bilateral substantia nigra degeneration.
  • Review of neurophysiological evidence supporting the hypothesis.

Related Experiment Videos

Main Results:

  • A patient with Huntington's disease experienced chorea cessation correlated with substantia nigra degeneration.
  • Hypothesized a balance between striatal atrophy (hyperkinesia) and substantia nigra atrophy (hypokinesia) in the patient.
  • Identified the substantia nigra pars compacta as a potential target for deep brain stimulation.

Conclusions:

  • Deep brain stimulation of the substantia nigra pars compacta may offer the first effective therapy for Huntington's chorea.
  • This approach could rebalance basal ganglia output in hyperkinetic movement disorders.
  • Further research is warranted to validate this neurosurgical intervention.